I. Hishinuma

发表

Involvement of tumor necrosis factor-alpha in the pathogenesis of activated macrophage-mediated hepatitis in mice.

J. Nagakawa, I. Hishinuma, K. Hirota, 1990, Gastroenterology.

Involvement of tumor necrosis factor‐α in development of hepatic injury in galactosamine‐sensitized mice

J. Nagakawa, I. Hishinuma, K. Hirota, 1990, Hepatology.

[Effects of E-3123, a new protease inhibitor, on several protease activities and on experimental acute pancreatitis].

J. Nagakawa, I. Hishinuma, K. Miyamoto, 1988, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Oral administration of the thrombin receptor antagonist E5555 (atopaxar) attenuates intimal thickening following balloon injury in rats.

I. Hishinuma, T. Matsuoka, H. Kuramochi, 2011, European journal of pharmacology.

Suppressive effects of E3330, a novel quinone derivative, on tumor necrosis factor-α generation from monocytes and macrophages

M. Yasuda, J. Nagakawa, I. Hishinuma, 1992, Agents and Actions.

Interleukin-Lα Enhances Hepatotoxicity of Tumor Necrosis Factor-α in Galactosamine-Sensitized Mice

M. Yasuda, J. Nagakawa, I. Hishinuma, 1991 .

Antipruritic Effect of the Topical Phosphodiesterase 4 Inhibitor E6005 Ameliorates Skin Lesions in a Mouse Atopic Dermatitis Model

I. Hishinuma, K. Miyazaki, N. Ishii, 2013, The Journal of Pharmacology and Experimental Therapeutics.

The novel and orally active thrombin receptor antagonist E5555 (Atopaxar) inhibits arterial thrombosis without affecting bleeding time in guinea pigs.

I. Hishinuma, T. Matsuoka, H. Kuramochi, 2011, European journal of pharmacology.

1102-48 Inhibitory effect of E5555, an orally active thrombin receptor antagonist, on intimal hyperplasia following balloon injury

I. Hishinuma, T. Matsuoka, T. Kawahara, 2004 .

Protective effects of E3330, a novel quinone derivative, on galactosamine/tumor necrosis factor-alpha-induced hepatitis in mice.

J. Nagakawa, I. Hishinuma, K. Hirota, 1992, European journal of pharmacology.

A novel type of retinoic acid receptor antagonist: synthesis and structure-activity relationships of heterocyclic ring-containing benzoic acid derivatives.

I. Hishinuma, S. Abe, S. Hibi, 1995, Journal of medicinal chemistry.

Mechanism of growth promotion of mouse lymphoma L1210 cells in vitro by feeder layer or 2‐mercaptoethanol

I. Hishinuma, T. Ishii, Y. Sugita, 1981, Journal of cellular physiology.

Calreticulin and integrin alpha dissociation induces anti-inflammatory programming in animal models of inflammatory bowel disease

K. Agarwala, M. Muratani, A. Fukamizu, 2018, Nature Communications.

Alpha-tocopherol and inhibition of cytolysis in glutathione-depleted hepatocytes in primary culture.

I. Hishinuma, T. Nakamura, T. Nakamura, 1988, Journal of nutritional science and vitaminology.

The α integrin cytoplasmic motif KXGFFKR is essential for integrin-mediated leukocyte adhesion

I. Hishinuma, M. Ohkuro, 2010 .

A putative antipruritic mechanism of the phosphodiesterase‐4 inhibitor E6005 by attenuating capsaicin‐induced depolarization of C‐fibre nerves

I. Hishinuma, N. Ishii, H. Wakita, 2015, Experimental dermatology.

Calreticulin and integrin alpha dissociation induces anti-inflammatory programming in animal models of inflammatory bowel disease

K. Agarwala, M. Muratani, A. Fukamizu, 2018, Nature Communications.

The alpha integrin cytoplasmic motif KXGFFKR is essential for integrin-mediated leukocyte adhesion.

I. Hishinuma, M. Ohkuro, 2010, International Journal of Molecular Medicine.

Protective effects of (2E)-3-[5-(2,3-dimethoxy-6-methyl-1,4- benzoquinoyl)]-2-nonyl-2-propenoic acid on endotoxin-mediated hepatitis in mice.

J. Nagakawa, I. Hishinuma, K. Hirota, 1992, The Journal of pharmacology and experimental therapeutics.

Protective effect of E3330, a novel quinone derivative, in galactosamine-induced hepatitis in rats.

J. Nagakawa, I. Hishinuma, K. Hirota, 1993, The Journal of pharmacology and experimental therapeutics.

Interleukin-1 alpha enhances hepatotoxicity of tumor necrosis factor-alpha in galactosamine-sensitized mice.

M. Yasuda, J. Nagakawa, I. Hishinuma, 1991, Immunopharmacology and immunotoxicology.